Bleeding Risk Following Percutaneous Coronary Intervention in Patients with Diabetes Prescribed Dual Anti-platelet Therapy

BACKGROUND: Patients with diabetes (DM) experience higher rates of in-stent restenosis and greater benefit from DES implant at the time of PCI, necessitating prolonged dual anti-platelet therapy (DAPT). While DAPT reduces risk of ischemic events post-PCI, it also increases risk of bleeding. Whether...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am Heart J
Main Authors: Grodzinsky, Anna, Arnold, Suzanne V., Wang, Tracy Y., Sharma, Praneet, Gosch, Kensey, Jones, Philip G., Bhatt, Deepak L., Steg, Philippe Gabriel, McGuire, Darren K., Cohen, David J., Spertus, John A., Chhatriwalla, Adnan K., Lind, Marcus, Graham, Garth, Kosiborod, Mikhail
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5357237/
https://ncbi.nlm.nih.gov/pubmed/27914490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2016.09.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados